Bourla argues the Street underestimates Pfizer's launched products such as Nurtec, which is already near $2 billion annualized.
I will mention 2 as just examples that I think people need to reevaluate their assessment. 1, it is regarding Nurtec. That we are already close to $2 billion this.the way if you annualize it. And the street has us almost $2.5 billion by year 2020.